title: Dalcetrapib: turning the tide for CETP inhibition?
authors: Department of Vascular Medicine, Academisch Medisch Centrum, Meibergdreef, 1105 AZ Amsterdam, Netherlands. e.s.stroes@amc.uva.nl
authors: Erik S G
authors: ES
authors: Stroes
authors: Diederik F
authors: DF
authors: van Wijk
mesh_terms: D000577:Amides; D000924:Anticholesteremic Agents / Q000008:administration & dosage*; D003324:Coronary Artery Disease / Q000517:prevention & control*; D023921:Coronary Stenosis / Q000517:prevention & control*; D003952:Diagnostic Imaging / Q000379:methods*; D004952:Esters; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008297:Male; D013438:Sulfhydryl Compounds / Q000008:administration & dosage*
chemical_list: D000577:Amides; D000924:Anticholesteremic Agents; D004952:Esters; D013438:Sulfhydryl Compounds; C411602:dalcetrapib